MGTA - Magenta Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
59,208
59,208
41,340
27,899
5,782
Selling General and Administrative
23,761
23,761
18,623
7,828
3,486
Total Operating Expenses
82,969
82,969
59,963
35,727
9,268
Operating Income or Loss
-82,969
-82,969
-59,963
-35,727
-9,268
Interest Expense
-
-
0
0
163
Income Before Tax
-76,769
-76,769
-57,515
-35,491
-9,431
Income from Continuing Operations
-76,769
-76,769
-57,515
-35,491
-9,431
Net Income
-76,769
-76,769
-57,515
-35,491
-9,431
Net Income available to common shareholders
-76,769
-76,769
-57,603
-35,491
-9,735
Basic EPS
-
-
-3.13
-2.07
-0.45
Diluted EPS
-
-
-3.13
-2.07
-0.45
Basic Average Shares
-
-
18,390
17,142
21,498
Diluted Average Shares
-
-
18,390
17,142
21,498
EBITDA
-
-81,126
-56,640
-35,115
-9,262